Myocard Biopsy Forcep

FDA 510(k) K881412 · Fehling Medizintechnik GmbH

Substantially Equivalent

510(k) numberK881412

Submission

Device name
Myocard Biopsy Forcep
Applicant
Fehling Medizintechnik GmbH
West Germany, DE
Received
April 4, 1988
Decision date
September 8, 1988
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)

Official FDA 510(k) record

Device classification

Product code
DWZ – Device, Biopsy, Endomyocardial
Device class
Class II (moderate risk)
Regulation
21 CFR 870.4075
Specialty
Cardiovascular

Other 510(k)s with product code DWZ

510(k)DeviceApplicantDecision
K252722Biopsy ForcepsDWZ · Special Fehling Instruments GmbH09/30/2025SE
K170726Biopsy ForcepsDWZ · Traditional Fehling Instruments GmbH & Co. KG06/02/2017SE
K072051Novatome, Model: SU101-50DWZ · Traditional Scholten Surgical Instruments, Inc.10/03/2007SE
K010473Sparrowhawk DisposableDWZ · Traditional Atc Technologies, Inc.06/06/2001SE
K000409Modification to T-Rex Biopsy ForcepsDWZ · Special Boston Scientific Corp02/28/2000SE
K991486Ultra-CbxDWZ · Traditional Medcanica, Inc.11/05/1999SE
K974175Heartport Endoaortic Clamp CatheterDWZ · Traditional Heartport, Inc.12/16/1997SE
K973818T-Rex Biopsy ForcepsDWZ · Traditional Boston Scientific Corp12/16/1997SE
K951447Dynabite Cardiovascular Biopsy ForcepsDWZ · Traditional Portlyn Corp.07/27/1995SE
K933235Cordis Bipal 7 /Biopsy & Bipal Biopsy Forceps, ModifDWZ · Traditional Cordis Corp.01/06/1994SE

Questions and answers

When was Myocard Biopsy Forcep cleared by the FDA?

Myocard Biopsy Forcep (K881412) received a 510(k) decision of Substantially Equivalent on September 8, 1988, 157 days after the submission was received.

What is the product code of K881412?

The FDA product code is DWZ – Device, Biopsy, Endomyocardial, a Class II (moderate risk) device regulated under 21 CFR 870.4075.